Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Psychoneuroendocrinology. 2014 Apr 6;45:142–153. doi: 10.1016/j.psyneuen.2014.03.018

Figure 1.

Figure 1

Location of NTS micropellets. (A) Example of micropellet placement directed to targeted NTS region as indicated by the black arrow. (B) Micropellet placement of animals subjected to acute restraint (experiment 1). (C) Location of micropellets of animals exposed to CVS (experiment 2). CHOL (30 μg): open circle; CORT (30 μg): grey triangle; mifepristone (30 μg): closed black circle. For experiment 1: n=8 (CORT implanted animal), n= 8 (mifepristone implanted animal), n=10 (CHOL implanted animals). For experiment 2: n= 8 (mifepristone implanted CVS rats), n=12 (CHOL implanted CVS rats), n=8 (mifepristone implanted no CVS rats), n=12 (CHOL implanted no CVS rats). Schematic coronal sections adapted from Paxinos and Watson (Paxinos and Watson, 1998). CC= Central canal, AP= area postrema, A2= adrenergic cell group, NTS= nucleus of solitary tract.

HHS Vulnerability Disclosure